The effects of Hsp90 expression alteration on spinal metastases of breast carcinoma

Tumor Biology

Volumn 34, Issue 3, 2013, Pages 1391-1397

  Yan, Wangjun ^a   Xiao, Jianru ^a   Liu, Tielong ^a   Huang, Wending ^a   Yang, Xinghai ^a   Wu, Zhipeng ^a   Huang, Quan ^a   Qian, Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

17 Allylamino demethoxy geldanamycin; Breast cancer; Hsp90; Real time PCR; Spinal metastases

Indexed keywords

HEAT SHOCK PROTEIN 90; MESSENGER RNA; TANESPIMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BONE INJURY; BREAST CANCER; BREAST CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD METASTASIS; WHOLE BODY IMAGING;

EID: 84878677607     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0584-z     Document Type: Article

References (21)

1. Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237-48.
2. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584-93.
3. Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 2005;10(2):169-80.
4. Salmon JM, Kilpatrick SE. Pathology of skeletal metastases. Orthop Clin North Am. 2000;31(4):537-44. vii-viii.
5. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst. 2000;92(19):1564-72.
6. Stangl K, Gunther C, Frank T, Lorenz M, Meiners S, Ropke T, Stelter L, Moobed M, Baumann G, Kloetzel PM, et al. Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. Biochem Biophys Res Commun. 2002;291(3):542-9.
7. Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC, Sessa WC, Altieri DC. Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A. 2003;100(24):13791.
8. Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis. 2007;28(6):1133-9.
9. Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Cancer Res. 2000;60(2):342-9.
10. Park JW, Yeh MW, Wong MG, Lobo M, Hyun WC, Duh QY, Clark OH. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. J Clin Endocrinol Metab. 2003;88(7):3346-53.
11. Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature. 1998;396(6709):336-42.
12. Kato A, Ushio Y, Hayakawa T, Yamada K, Ikeda H, Mogami H. Circulatory disturbance of the spinal cord with epidural neoplasm in rats. J Neurosurg. 1985;63(2):260-5.
13. Takahashi M, Ogawa J, Kinoshita Y, Takakura M, Mochizuki K, Satomi K. Experimental study of paraplegia caused by spinal tumors: an animal model of spinal tumors created by transplantation of VX2 carcinoma. Spine J. 2004;4(6):675-80.
14. Amundson E, Pradilla G, Brastianos P, Bagley C, Riley 3rd LH, Garonzik IM, McCarthy E, Wolinsky JP, Gokaslan ZL. A novel intravertebral tumor model in rabbits. Neurosurgery. 2005;57(2):341-6. discussion 341-346.
15. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 1988;48(23):6876-81.
16. Arguello F, Furlanetto RW, Baggs RB, Graves BT, Harwell SE, Cohen HJ, Frantz CN. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res. 1992;52(8):2304-9.
17. Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, Mehlen P, Arrigo A, Clézardin P, Diaz-Latoud C. Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer. 2012;107:63-70.
18. Zhao Z, Cheng CF, Kim R, Chen M, Woodley D, Li W: Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression. In: 2010: BioMed Central Ltd; 2010: O14.
19. Sims JD, McCready J, Jay DG. Extracellular heat shock protein (Hsp) 70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One. 2011;6(4):e18848.
20. Isaacs JS, Xu W, Neckers L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell. 2003;3(3):213-7.
21. Neckers L. Heat shock protein 90: the cancer chaperone. J Biosci. 2007;32(3):517-30.